🎉 Congratulations to postdoctoral researcher Dr Pavitha Parathan for becoming the first-ever recipient of Pancare Foundation's Eliza Wilmot Scholarship. ➡️ Read more: https://ow.ly/zJ0150Z1rF2

🎉 Congratulations to PhD student Birhanu Ayelign for receiving an Abacus Dx 2026 Emerging Investigators Grant to advance his phage therapy research in gastric cancer. #gastriccancer #phagetherapy

Congratulations to Prof Eliza Hawkes, her team and collaborators who received a $1.9m Cancer Australia grant to activate the iLIMM lymphoma study. Objectives: • Advanced tumour and immune system mapping • Testing whether physical exercise could improve outcomes ➡️ https://ow.ly/a8KN50YVmKN #NHMRC

Results from ONJCRI’s MoST-CIRCUIT clinical trial suggest that combination immunotherapy with nivolumab and ipilimumab is a promising avenue for hard-to-treat gallbladder cancer patients. ➡️ https://ow.ly/RLX450YT3pI #ClinicalTrials #GallbladderCancer #BiliaryTractCancer #immunotherapy

Congratulations to Kaitlyn Kew on receiving a Tour de Cure PhD Scholarship 👏 Her research is on children with B-cell acute lymphoblastic leukaemia (B-ALL). With ~10% of patients experiencing relapse, this work could help drive more effective treatments. #CancerResearch #PhD #Leukaemia

Congratulations to our researchers who were awarded funding from Tour de Cure to pursue innovative and impactful cancer research projects. • Dr Bhupinder Pal • Dr Zhipeng Cao • Dr Rebekah Crake ➡️ Read more: https://ow.ly/HARX50YKLUi #CancerResearch #ResearchFunding

Congratulations to Tawany De Carvalho Gil, awarded a PhD Top-Up Scholarship from the Jreissati Pancreatic Cancer Centre! Her research uses antibody-based biomarkers as an early warning system for pancreatic cancer detection.

Prof Andrew Scott played a key role in the development of a new global agreement that will improve the standardisation of medical imaging data from clinical trials, developed by ARTnet, SNMMI CTN and EARL. ➡️ https://ow.ly/V0os50YIC9p #NCRIS20 #NCRISimpact

Australia's premier CRISPR conference is back! 🧬 Accelerate your research, and spend two days connecting with international and local experts on cutting-edge gene editing. March 24-25 | Melbourne Connect Register: crispr.org.au Register now ➡️ http://crispr.org.au #CRISPR #CDU2026 #CRISPRDownUnder

Researchers from ONJCRI, WEHI and Peter Mac have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies. In a world-first, the team were able to detect the DNA barcodes shed by the primary tumour in plasma samples. ➡️ https://ow.ly/fcK550Yc0WN

🌏 Last night we marked World Cancer Day with a public event at ONJCRI, co-hosted with La Trobe Institute for Molecular Science (LIMS). Our community explored cutting-edge cancer research and heard from an inspiring panel. Thank you to all who joined us! Read more: https://ow.ly/U6Hp50Y98im

🎉 Proud to share that Dr Andrew Guirguis has been awarded a Cancer Council Victoria fellowship to investigate how pre-leukaemic blood conditions progress to acute leukaemia, and how that progression could be stopped. ➡️ Read: https://ow.ly/6AiY50Y5Laf #CancerResearch #CCV #CRFV #BloodCancer

We are delighted to share that recruitment for our Phase II VADER trial for patients with advanced bowel cancer is now complete, at nine centres across Australia. ➡️ Learn more: https://ow.ly/jfI450Y0ZtS AGITG and GI Cancer Institute #CancerTrials #BowelCancer #ColorectalCancer

A feature in Nature explores how researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment. #medsky 🧪

ONJCRI is thrilled to announce that Prof Eliza Hawkes and Prof Hui Gan have received MRFF Clinical Trials Activity funding to lead new and impactful clinical trials for blood and brain cancer patients. ➡️ https://ow.ly/mEgi50XZUuX #ClinicalTrials #CancerTrials #Glioblastoma #Lymphoma #MRFF

‘The Beginning’ by Rebecca Brown, PhD student 💡 Discover our Science Meets Art masterpieces: https://sciencemeetsart.com.au/shop/ #ScienceMeetsArt #MicroscopyArt #BreastCancerResearch

🔬 Thank you for being on the journey with our team in 2025. We look forward to sharing our breakthroughs and impact stories with you in 2026. If you would like to stay up to date with our news, subscribe to our newsletter: https://www.onjcri.org.au/subscribe-to-our-newsletter/ #CancerResearch

‘The Second Brain in the Colon’ by Dr Pavitha Parathan, Postdoctoral Researcher  💡 Discover our Science Meets Art masterpieces: https://sciencemeetsart.com.au/shop/ #ScienceMeetsArt #MicroscopyArt #BowelCancer

‘Crystal Nebula’ by Andrew Li, PhD student 💡 Discover our Science Meets Art masterpieces: https://ow.ly/mcti50XGCWW #ScienceMeetsArt #ArtInScience #ResearchArt

Have you been directly impacted by cancer, as a patient, carer or loved one? Your voice can transform outcomes for cancer patients. ➡️ Learn about our Patient Advocacy Program: https://ow.ly/1qL950XHXMf #PatientAdvocates #PatientAdvocacy #CancerAdvocates #PatientVoice

ONJCRI and WEHI (The Walter and Eliza Hall Institute of Medical Research) researchers have discovered that the TAK1 gene acts like a molecular safety switch, protecting cancer cells from attack by the immune system. ➡️ Read more: https://ow.ly/YtVW50XLgyq #TAK1 #CancerResearch #Immunotherapy

An important review exploring how the gut microbiome may act as an immune gate-keeper in B-cell lymphoma has been published in Blood Reviews. The review was authored by our team specialising in lymphoma and collaborators at QIMR Berghofer ➡️ https://ow.ly/coGe50XKHwl #BCellLymphoma Prof Eliza Hawkes

860+ emails have gone to MPs across 130 electorates calling for the full Medical Research Future Fund in the 2026–27 Federal Budget Medical research pays for itself - every $1 returns $3.90 Let it fund tomorrow - share your voice: www.aamri.org.au/mrff #releasethefullmrff

Stomach cancer is often caught late and hard to treat, but Dr Lisa Mielke's team at ONJCRI is changing that. By uncovering how the nervous system fuels stomach & bowel cancer growth, they are opening doors to new treatments. Learn more: https://ow.ly/Lt9x50Xve2T #StomachCancer #BowelCancer

A study led by WEHI and @onjcri.org.au has uncovered a new way to track heterogeneous breast cancer cells as they metastasise to secondary organs. The findings could lead to a powerful new tool to study the complexity of metastatic breast cancer. Published in NPJ Imaging: rdcu.be/eOKdU

We are delighted to share that A/Prof Peter Janes and A/Prof Doug Fairlie have received Pankind 2025 Research Grants, allowing them to make strides in their pancreatic cancer research. ➡️ Read more: https://ow.ly/Coqq50XsqUl #PancreaticCancer #CancerResearch #ResearchGrants #ONJCRI

Significant new results from ONJCRI’s Phase II rare cancer clinical trial on combination immunotherapy in dMMR/MSI-H non-colorectal cancers have been published in @jamaoncology.com. ➡️ Learn more: jamanetwork.com/journals/jam... #RareCancers #RareCancerTrial #ClinicalTrials #ONJCRI

ONJCRI researchers have found that differentiation grade does not change significantly following cancer spread, suggesting that studying the primary tumour alone will be sufficient to understand the metastasis in most cases. ➡️ Full paper: https://ow.ly/SK0T50XmUct #ColorectalCancer #CancerResearch

ONJCRI was delighted to host our third Science Meets Art exhibition, welcoming members of the community, patient advocates and our supporters. A huge thank you to the North East Community Fund, the artists and the dedicated Committee who made this event come to life! ➡️ https://ow.ly/YGyK50XmSni

ONJCRI joins AAMRI in calling on the Federal Government to release the full MRFF in the 26–27 Federal Budget. The MRFF was created to deliver $1 billion every year for lifesaving research, but currently, only about $650 million is being released. Visit aamri.org.au/mrff/ #releasethefullMRFF

Our fantastic @onjcri.org.au and @lardr.bsky.social teams presenting lymphoma research orals at #HSANZ Blood conference in Perth. Dr Liz Goodall, Dr Allison barraclough, Eliza Chung and Rebecca nightingale and Dr Arina Martynchyk. All rising @womeninlymphoma.bsky.social

New trial sites have been activated for the advanced #cholangiocarcinoma BIL-PPP phase II study in VIC, NSW, QLD and SA, making it accessible to more Australians. ➡️ Learn more: https://ow.ly/xqo650XjsBM#cholangiocarcinoma The BIL-PPP trial is funded by the Wayne Elphinstone Memorial Fund, AstraZeneca and AGITG

Catch ONJCRI’s Dr Pavitha Parathan and Dr @davidyiju.bsky.social on @drshanerrr.bsky.social’s RRR program, Einstein A Go-Go this morning 📻 Talking bowel cancer and novel cancer treatment delivery systems 🔬 #sciencemedia #cancerresearch

ONJCRI researchers have linked two nervous system components to bowel cancer growth, creating promising new avenues for treatment with existing approved migraine therapies. The findings were published in The BMJ Oncology today. ➡️ https://ow.ly/PCFE50XfWVh #BowelCancer #Neuropeptides #ONJCRI

We are thrilled to be partners with the @cccolab.bsky.social and are looking forward to working together to improve outcomes for children with cancer.

This National Carers Week, we celebrate the significant role of carers in the lives of people with cancer by sharing the powerful story of one of ONJCRI’s valued supporters. ➡️ Read Gary's story: https://ow.ly/JZQV50XaRtu

ONJCRI researchers and collaborators at @unimelb.bsky.social and RMIT have developed a novel nanomedicine delivery system with highly ordered structures that enhance cargo delivery to their targets. ➡️ Read the paper: ow.ly/XmYX50X1j4I #LipidNanoparticles #Nanomedicine #CancerResearch

Today, we celebrate World Cancer Research Day, a recognition of the vital role of research in improving cancer outcomes and reducing the global cancer burden. ➡️ Learn more about our research: www.onjcri.org.au/ou... #WorldCancerResearchDay

We are thrilled to announce Prof @elizahawkes.bsky.social Hawkes, the Chief Clinical Research Officer at the Olivia Newton-John Cancer Research Institute and #Lymphoma doc at Austin Health, as a speaker at #NDLR2026. Eliza’s interests are implementing novel #CancerTherapies into #ClinicalTrails.

Researchers at ONJCRI, the University of Washington and @wehi-research.bsky.social have created novel "designer proteins" that can both activate and block cell death as required under different conditions. ➡️ Read the Science Advances paper: ow.ly/5glk50WSRnT #CellDeath #Apoptosis #ONJCRI

Researchers at ONJCRI, @wehi-research.bsky.social and @petermaccc.bsky.social have discovered that a known protein complex can stop a common type of blood cancer in its tracks. The findings were published in @natcomms.nature.com ➡️ Read more: ow.ly/Ca4S50WHVrA #Lymphoma #CRISPR

📚 Congratulations to Dr Sarah Yeo, lead author of TRACKER Biobank's first peer-reviewed publication, which explores the challenges and future directions for lung cancer biobanking in Australia. Read the review here: ow.ly/jlvA50Wze5Y #LungCancerResearch #CancerResearch #Biobank #ONJCRI

Today, we stand with patients, families, clinicians, and researchers to raise awareness of lung cancer. - 36 Australians are diagnosed with lung cancer each day - Lung cancer claims the most lives of any cancer in Australia - Less than 6% of cancer research funding is allocated to thoracic cancers

Bowel cancer rates are rising in young people, and researchers are working tirelessly to find out why, writes Dr Lisa Mielke buff.ly/SpTGiBQ @onjcri.org.au @lisa-mielke.bsky.social

🎗️ This World Head and Neck Cancer Day, we're highlighting ONJCRI's START-HN trial: a game-changing combination of precision radiotherapy and revolutionary immune monitoring techniques that can track how immune cells respond to treatment. Read more here: ow.ly/el1V50WvBBy

We are thrilled to share that the ACRF Centre for Precision Medicine has officially opened at ONJCRI. Thank you to ACRF for making this new facility become a reality. ➡️ Read more about our new Centre: ow.ly/mcJl50WtK57 #ACRF #CancerResearch #PrecisionMedicine #ONJCRI

💡 Breakthrough in rare cancer care Research led by Prof Eliza Hawkes shows that 3D imaging can revolutionise how we monitor treatment for primary central nervous system lymphoma (PCNSL), a rare but aggressive cancer. Read the full study here: ow.ly/Nler50WqYMI

🧠 This Glioblastoma (GBM) Awareness Day, we highlight The Centre for Research Excellence in Brain Cancer's Biomarkers in Brain project. "This valuable resource will allow us to push forward with research to find better treatments for GBM patients.” ➡️ Learn more: ow.ly/NFAm50Wqiel

Congratulations to Dr Lisa Mielke, who received a prestigious Australian Research Council (ARC) Future Fellowship totalling $1.13 million to research new molecules for future drug and vaccine development. ➡️ Learn more: ow.ly/GSAP50Wo6L1 #FutureFellowship #ONJCRI

🎯 Game-changer for lymphoma treatment ONJCRI researchers have cracked the code on predicting which blood cancer patients will respond best to a powerful combo of radiotherapy and immunotherapy. In @bloodjournals.hematology.org Read more on our website: ow.ly/CnZc50Wo6gw #Cancer #Lymphoma